Skip to main content
. 2019 Jul 31;30(10):1973–1982. doi: 10.1007/s00198-019-05097-1

Fig. 2.

Fig. 2

Kaplan-Meier estimated risk and relative risk (bisphosphonate users versus controls) of death in the matched cohort during the first 3 years after initiation of bisphosphonate (BP) treatment. In the bottom panel, the solid line indicates relative risk and the dashed lines indicate 95% confidence intervals